Home › Funds › Catalio Capital Management, LP › ELDN
Catalio Capital Management, LP position in ELDN
ELEDON PHARMACEUTICALS INC · Health Care
Catalio Capital Management, LP reported holding 1,695,071 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$6.7M, representing 1.26% of its reported portfolio and ranking #26 among its reported holdings. Catalio Capital Management, LP has disclosed ELDN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's ELDN position evolved
Catalio Capital Management, LP first disclosed a stake in ELDN in Q3 2025 at 1,061,132 shares (US$2.7M). The position peaked in Q2 2026 at 1,695,071 shares, worth US$6.7M. Across 4 filings, Catalio Capital Management, LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,695,071 shares valued at US$6.7M — an increase of 55,255 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2026 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.06M | $2.75M | New |
| Q4 2025 | 1.26M | $1.90M | Add |
| Q1 2026 | 1.64M | $5.05M | Add |
| Q2 2026 | 1.70M | $6.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELDN and 13F data
ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), SPHERA FUNDS MANAGEMENT LTD. (US$4.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELDN
- BVF INC/IL 6.29M sh · $24.80M · Q2 2026
- Defilade Capital Management, L.P. 3.53M sh · $13.89M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.19M sh · $4.69M · Q2 2026
- 22NW, LP 636.36K sh · $2.51M · Q2 2026
- CM Management, LLC 575.00K sh · $2.27M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held ELDN?
Catalio Capital Management, LP has disclosed ELDN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Catalio Capital Management, LP's current position in ELDN?
As of Q2 2026, Catalio Capital Management, LP holds 1.70M shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $6.68M, representing 1.26% of its reported portfolio and ranking #26.
Has Catalio Capital Management, LP been buying or selling ELDN?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP increased its position in ELDN. The position peaked in Q2 2026 at 1.70M shares.
Which other funds hold ELDN?
Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., SPHERA FUNDS MANAGEMENT LTD., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.